Community racial and ethnic representation among physicians in US internal medicine residency programs
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Apr-2025 01:08 ET (30-Apr-2025 05:08 GMT/UTC)
Girish N. Nadkarni, MD, MPH, CPH, an accomplished physician-scientist driving advances in artificial intelligence, has been appointed Chair of the Windreich Department of Artificial Intelligence and Human Health at the Icahn School of Medicine at Mount Sinai. The department is the first of its kind at a U.S. medical school, underscoring Mount Sinai's leadership in integrating artificial intelligence (AI) into health care. Dr. Nadkarni will also serve as Director of the Hasso Plattner Institute for Digital Health. The appointment marks the latest milestone in a series of progressive initiatives by Mount Sinai to harness and optimize artificial intelligence for transformative health care solutions. Recent developments include the launch of its state-of-the-art AI facility, designed to accelerate innovation and collaboration in translational medicine. Other developments include an exciting, soon-to-be-announced tool exclusively available to students at the Icahn School of Medicine at Mount Sinai. This initiative is poised to redefine how AI is integrated into medical education and research, empowering students with cutting-edge resources. The institution has also significantly expanded its computational and data ecosystem, highlighted by its supercomputing cluster—the largest at any academic medical center in the world.
Flexible perovskite solar cells are promising for lightweight and versatile applications but their sensitivity to humidity and temperature poses a challenge to long-term durability. To address this, researchers from Japan have conducted a comprehensive study to test the degradation of these solar modules under extreme heat and humidity. Through accelerated testing, they identified how the water vapor transmission rates of barrier films affect the module’s stability, giving critical insights for development of durable solar cells.
Propranolol, a beta blocker medication used for treating high blood pressure and preventing migraines, may lower ischemic stroke risk in women who experience migraines frequently.
Both F.A.S.T. and BE-FAST acronyms motivated people to call 911 right away for a possible stroke, and this impact lasted for 30 days.